Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

Reoperations May Offer Survival Benefit in Recurrent Glioblastoma

February 8th 2025, 7:00pm

Article

When deciding if reoperation is an option in recurrent glioblastoma, factors like tumor location, therapy history and patient health should be considered.

Tafinlar/Mekinist Combo is Safe, Effective in Patients With Glioma

February 7th 2025, 10:00pm

Article

Treatment with Tafinlar in combination with Mekinist showed what researchers described as “considerable efficacy” among patients with gliomas.

Radiotherapy and Temozolomide Improve PFS in IDH-Wildtype Glioblastoma

February 6th 2025, 10:00pm

Article

Concomitant radiotherapy plus temozolomide significantly increased progression-free survival versus radiotherapy alone in IDH-wildtype glioblastoma.

Dwyane Wade Talks Tumor Removal, Bachelorette Star’s Husband Cancer Diagnosis and More

January 31st 2025, 4:00pm

Article

From the reveal of NBA star Dwyane Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is this week’s top cancer news.

Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

January 24th 2025, 4:00pm

Article

From the deaths of John Sykes and former Planned Parenthood President Cecile Richards to an update from Mike Peters, here’s this week’s cancer news.

Short-Course Radiation Aids Survival in Older Patients With Glioblastoma

January 7th 2025, 2:00pm

Article

18F-DOPA PET−guided, dose-escalated, hypofractionated proton beam therapy led to improved OS in older patients with newly diagnosed glioblastoma.

Veliparib and Temozolomide Combo Does Not Significantly Extend Survival for Patients With Glioma

January 6th 2025, 4:00pm

Article

Veliparib plus temozolomide did not significantly extend overall survival in patients with newly diagnosed, MGMT-hypermethylated glioblastoma.

FDA Reviews NDA for Dordaviprone in Recurrent H3 K27M-Mutant Diffuse Glioma

January 4th 2025, 3:00pm

Article

Chimerix submitted a new drug application to the FDA seeking accelerated approval for dordaviprone to treat patients with recurrent H3 K27M-mutant diffuse glioma.

Brain Cancer Survivor Reflects on Memoir and Her Journey

December 9th 2024, 2:00pm

Video

Maggie Bushway reflected on her memoir “Pearls: A Memoir on Childhood Cancer and Hope,” and her journey of healing and resilience after brain cancer.

Combination Treatment May Improve Survival in Recurrent Brain Cancer Subtype

November 27th 2024, 2:00pm

Article

Survival improved in patients with recurrent grade 3 IDH-mutant astrocytoma who were treated with eflornithine and lomustine.